About this trial
The Biceps Femoris Short Head (BiFeS) block is a new fascial plane block technique targeting the sensory innervation of the posterolateral capsule of the knee while preserving motor function. The aim of this study is to evaluate the postoperative analgesic efficacy of the BiFeS block combined with the adductor canal block (ACB) in patients undergoing total knee arthroplasty, compared to ACB + iPACK block. The study is planned as a prospective, randomized, double-blind, parallel two-group trial. Patients will be randomized in a 1:1 ratio to receive ACB + iPACK (Group A) or ACB + BiFeS (Group B). Postoperative pain scores (VAS), opioid consumption, early mobilization, and quality of recovery (QoR-15) outcomes will be compared.
Eligibility criteria
Qualifiers
Scheduled for unilateral total knee arthroplasty
Classified as ASA physical status I-III
Disqualifiers
Scheduled for revision arthroplasty or bilateral surgery
Allergy to local anesthetics or contraindication to regional blocks
Neurological disorders, peripheral neuropathy, or conditions affecting lower extremity muscle strength
Coagulopathy or receiving anticoagulant therapy
Trial design
Treatments tested in this trial
- Biceps Femoris Short Head Block (BiFeS)
- Infiltration Between The Popliteal Artery and The Capsule of The Knee
- Adductor Canal Block